ENSG Stock Analysis: Buy, Sell, or Hold?
ENSG - The Ensign Group, Inc.
$188.30
-1.64 (-0.86%)
▼
5d:
-1.79%
30d:
-6.16%
90d:
+9.48%
HOLD
MODERATE Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 05, 2026
5d
Smart Money Accumulation
ENSG is down 3.9% this week, but smart money is accumulating calls. Top strike: $200 2026-06-18 with 53 OI. Call ratio: 100% View Scanner →
Strength: 6.9/10
Get Alerted When ENSG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENSG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ENSG shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$281.37
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$174.71
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ENSG is currently trading at $188.30, which is considered oversold relative to its 30-day fair value range of $192.58 to $202.88. The stock's valuation (Forward PE: 22.9) is in line with its historical norms (24.6). Remarkably, the market is currently pricing in an annual earnings decline of 2.4% over the next few years. This pessimistic expectation contrasts with the company's recent 18.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ENSG is in a strong uptrend. The price is currently testing key support at $185.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ENSG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $220.40 (+17.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENSG is in a strong uptrend. The price is currently testing key support at $185.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ENSG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $220.40 (+17.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$192.58 -
$202.88
Company Quality Score
54/100
(HOLD)
Options IV Signal
45th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
57.7%
Protect Your Profits
Holding ENSG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 45th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($220.40)
Trading Range Analysis
30-Day Trading Range
$192.58 -
$202.88
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$11.48
(6.1%)
Support & Resistance Levels
Support Level
$185.00
Resistance Level
$203.85
Current Trend
Strong Uptrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.86
Wall Street Target
$220.40
(+17.0%)
Revenue Growth (YoY)
20.2%
Earnings Growth (YoY)
18.4%
Profit Margin
6.8%
Valuation Discount vs History
-2.4% cheaper
PE vs Historical
22.9 vs 24.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.4%
(market-implied from PE analysis)
1-Year Target
$183.78
(-2%)
2-Year Target
$179.37
(-5%)
3-Year Target
$175.07
(-7%)
3-Yr Target (if PE normalizes)
(PE: 23→25)
$188.43
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.9, Growth: 9.6%)
$247.91
(+32%)
Base:
(SPY PE: 20.6, Growth: 9.6%)
$223.55
(+19%)
Bear:
(PE: 17.5, Growth: 9.6%)
$190.02
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 32.47 | Current EPS (TTM): $5.85
Bull Case
$294.25
(+56%)
Analyst growth 40.8%, PE expands to 35.7
Base Case
$267.50
(+42%)
Market implied 40.8%, PE stable at 32.5
Bear Case
$129.16
(-31%)
Severe decline -20.0%, PE contracts to 27.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.9 to 24.6
Stabilization Target:
$202.67
(+7.6%)
PE Expansion Potential:
+7.6%
Share & Embed Analysis
Last updated: April 29, 2026 4:37 AM ET
Data refreshes hourly during market hours. Next update: 5:37 AM
Data refreshes hourly during market hours. Next update: 5:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENSG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
John O Agwunobi
SELL
392 shares
2026-04-20
Mark Vincent Parkinson
SELL
100 shares
2026-04-16
Barry M Smith
SELL
700 shares
2026-04-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$263 | 57 HOLD |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$535 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 58 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$139 | 64 BUY |
Advanced ENSG Option Strategies
Professional options setups generated by AI based on today's ENSG price and gamma walls.
